1. SIGNIFICANCE OF ETV6-RUNX1 FUSION GENE TRANSCRIPT DETECTION IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH TRANSLOCATION t(12;21)(p13;q22)
- Author
-
Alexander Popov, Tsvirenko Sv, T. Yu. Verzhbitskaya, A. A. Vlasova, Olga Streneva, Olga Makarova, Grigory Tsaur, Larisa Fechina, L. V. Vakhonina, О. R. Arakaev, Yu. V. Olshanskaya, Leonid Saveliev, Т. О. Riger, and А. N. Kazakova
- Subjects
medicine.medical_specialty ,Concordance ,Chromosomal translocation ,acute lymphoblastic leukemia ,Gastroenterology ,Flow cytometry ,Fusion gene ,children ,hemic and lymphatic diseases ,Internal medicine ,medicine ,translocation t(12 ,Diseases of the blood and blood-forming organs ,Cumulative incidence ,Childhood Acute Lymphoblastic Leukemia ,ABL ,medicine.diagnostic_test ,business.industry ,q22) ,Hematology ,Minimal residual disease ,etv6-runx1 fusion gene transcript ,Oncology ,minimal residual disease ,21)(p13 ,RC633-647.5 ,business - Abstract
Introduction. Translocation t(12;21)(p13;q22) is one of the most common structural genetic abnormalities in childhood acute lymphoblastic leukemia (ALL). It cannot be detected by conventional G-banding, so a reverse-transcriptase polymerase chain reaction (RT-PCR) or fluorescent in situ hybridization are used for this purpose. The aim of the study was to evaluate the prognostic significance of qualitative and quantitative detection of ETV6-RUNX1 fusion gene transcript at various time points in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Materials and methods. ETV6-RUNX1 fusion gene transcript was revealed by both reverse-transcriptase PCR and quantitative real-time PCR (RQ-PCR) in 34 out of 166 (20.5 %) children with BCP-ALL. Qualitative ETV6-RUNX1-positivity at days 36 and 85 led to unfavorable outcome (lower event-free survival –EFS and higher cumulative incidence of relapse – CIR). While ETV6-RUNX1 status at day 15 did not allow to divide patients with different outcomes. By ROC curve analysis we determined threshold levels (TL) for ETV6-RUNX1/ABL1 ratio at days 0, 15, 36 and 85. Afterwards we adjusted obtained results to 10-fold scale. Results. So practically applicable TL were as follows 500.0 %, 1 %, 0.1 % и 0.01 % for days 0, 15, 36 and 85, respectively. EFS and CIR were both worse in patients with ETV6-RUNX1/ABL1 ratio equal or above defined TL. Moreover, initial ratio ≥500,0 % corresponded to delayed blast clearance at days 15 and 36. We showed good qualitative (84.8 %) and quantitative (R 2 = 0.953) concordance between ETV6-RUNX1/ABL1 ratio and MRD data obtained by flow cytometry at days 15, 36, 85. Of note, defined TL for ETV6-RUNX1/ABL1 at days 15, 36, 85 were equal to prognostically important levels for flow cytometry MRD. Conclusion. Thus, qualitative detection and quantitative value of ETV6-RUNX1 fusion gene transcript showed prognostic significance in the course of treatment in children with BCP-ALL. Based on these results we propose standardization approaches for Moscow – Berlin ALL study group.
- Published
- 2018